Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Primary Invasive Malignant Neoplasm of Female Breast|Carcinoma Breast|Breast Cancer Female|Carcinoma, Ductal, Breast|Stage II Breast Cancer|Stage I Breast Cancer|Stage III Breast Cancer
Interventions: DEVICE: Investigational Imaging device|DRUG: AVB-620
Sponsor: Avelas Biosciences, Inc.
Collaborators: RRD International, Inc.|Clinipace Worldwide